- Home
- GIGM vs ISPC Comparison
GIGM vs ISPC Comparison
Compare GIGM & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GIGM
- ISPC
- Stock Information
- Founded
- GIGM 1998
- ISPC 2009
- Country
- GIGM Taiwan
- ISPC United States
- Employees
- GIGM N/A
- ISPC N/A
- Industry
- GIGM Computer Software: Programming Data Processing
- ISPC Precision Instruments
- Sector
- GIGM Technology
- ISPC Health Care
- Exchange
- GIGM Nasdaq
- ISPC Nasdaq
- Market Cap
- GIGM 17.0M
- ISPC 16.0M
- IPO Year
- GIGM 2000
- ISPC 2021
- Fundamental
- Price
- GIGM $1.83
- ISPC $1.69
- Analyst Decision
- GIGM
- ISPC
- Analyst Count
- GIGM 0
- ISPC 0
- Target Price
- GIGM N/A
- ISPC N/A
- AVG Volume (30 Days)
- GIGM 23.8K
- ISPC 20.2M
- Earning Date
- GIGM 10-29-2025
- ISPC 11-06-2025
- Dividend Yield
- GIGM N/A
- ISPC N/A
- EPS Growth
- GIGM N/A
- ISPC N/A
- EPS
- GIGM N/A
- ISPC N/A
- Revenue
- GIGM $3,250,000.00
- ISPC $5,908,088.00
- Revenue This Year
- GIGM N/A
- ISPC $35.93
- Revenue Next Year
- GIGM N/A
- ISPC N/A
- P/E Ratio
- GIGM N/A
- ISPC N/A
- Revenue Growth
- GIGM N/A
- ISPC N/A
- 52 Week Low
- GIGM $1.30
- ISPC $0.64
- 52 Week High
- GIGM $1.89
- ISPC $8.30
- Technical
- Relative Strength Index (RSI)
- GIGM 69.35
- ISPC 59.80
- Support Level
- GIGM $1.61
- ISPC $1.05
- Resistance Level
- GIGM $1.89
- ISPC $2.58
- Average True Range (ATR)
- GIGM 0.09
- ISPC 0.44
- MACD
- GIGM 0.03
- ISPC 0.11
- Stochastic Oscillator
- GIGM 85.71
- ISPC 41.34
About GIGM GigaMedia Limited
GigaMedia Ltd is a diversified provider of digital entertainment services. Its only segment and principal business is digital entertainment service business, which operates a portfolio of digital entertainment products, targeting digital entertainment service users across Asia. It operates digital entertainment business in Taiwan, Hong Kong and Macau through FunTown.
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.